Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain

Details for Australian Patent Application No. 2003294470 (hide)

Owner Alexza Pharmaceuticals, Inc.

Inventors Munzar, Patrik; Hale, Ron L.; Rabinowitz, Joshua D.

Agent Davies Collison Cave

Pub. Number AU-B-2003294470

PCT Number PCT/US2003/0374

PCT Pub. Number WO2004/047844

Priority 60/429,405 26.11.02 US

Filing date 20 November 2003

Wipo publication date 18 June 2004

Acceptance publication date 17 September 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

Event Publications

22 April 2004 Complete Application Filed

  Priority application(s): 60/429,405 26.11.02 US

22 July 2004 Application Open to Public Inspection

  Published as AU-B-2003294470

15 December 2005 Assignment before Grant

  Alexza Molecular Delivery Corporation The application has been assigned to Alexza Pharmaceuticals, Inc.

18 January 2007 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Munzar, Patrick to Munzar, Patrik

17 September 2009 Application Accepted

  Published as AU-B-2003294470

21 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003294471-METHOD FOR COUNTERACTING A PATHOLOGIC CHANGE IN THE ssADRENERGIC PATHWAY

2003294469-GAS SUPPLY AND RECOVERY FOR METAL ATOMIZER